Skip to main content

Research

Financial analyses and reports to support institutional and corporate customers in their investment decisions.

February 15, 2024

FY 23 results met guidance and FY 24 guidance in line with previous outlook

January 11, 2024

Post-integration of Luminex, Diasorin plots new growth pathways

December 11, 2023

AWEsomely poised to spark the hydrogen transition

July 04, 2023

Sound business model

June 08, 2023

Italian omnichannel betting champion with significant growth upside

June 07, 2023

Q1 confirmed the strong 2023 guidance, waiting for the plan update